Overview

Clinical Trial to Evaluate the Efficacy and Safety of 'Pelubiprofen Controlled Released Tab.' in Acute Traumatic Injury

Status:
Unknown status
Trial end date:
2019-12-31
Target enrollment:
Participant gender:
Summary
A randomized, double-blind, placebo-controlled, parallel, multi-center phase III clinical trial
Phase:
Phase 3
Details
Lead Sponsor:
Daewon Pharmaceutical Co., Ltd.